Vocational education Universal Technical Institute (NYSE:UTI) announced better-than-expected revenue in Q1 CY2025, with sales up 12.6% year on year to $207.4 million. The company’s full-year revenue guidance of $830 million at the midpoint came in 2% above analysts’ estimates. Its GAAP profit of $0.21 per share was 72.6% above analysts’ consensus estimates.
Online home goods retailer Wayfair (NYSE:W) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $2.73 billion. Its non-GAAP profit of $0.10 per share was significantly above analysts’ consensus estimates.
Luxury fashion conglomerate Tapestry (NYSE:TPR) announced better-than-expected revenue in Q1 CY2025, with sales up 6.9% year on year to $1.58 billion. The company’s full-year revenue guidance of $6.95 billion at the midpoint came in 1.1% above analysts’ estimates. Its GAAP profit of $0.95 per share was 7.5% above analysts’ consensus estimates.
Restaurant technology provider PAR Technology (NYSE:PAR) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 48.2% year on year to $103.9 million. Its non-GAAP loss of $0.01 per share was 76.7% above analysts’ consensus estimates.
Fertility benefits company Progyny (NASDAQ:PGNY) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 16.5% year on year to $324 million. The company expects next quarter’s revenue to be around $317.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 7.7% above analysts’ consensus estimates.
Boutique fitness studio franchisor Xponential Fitness (NYSE:XPOF) reported Q1 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.5% year on year to $76.88 million. The company expects the full year’s revenue to be around $320 million, close to analysts’ estimates. Its non-GAAP loss of $0.20 per share was significantly below analysts’ consensus estimates.
Pool products retailer Leslie’s (NASDAQ:LESL) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 6.1% year on year to $177.1 million. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $1.34 billion at the midpoint. Its non-GAAP loss of $0.25 per share was 4.6% below analysts’ consensus estimates.
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 5.8% year on year to $599.5 million. Its non-GAAP profit of $1.72 per share was 34.4% above analysts’ consensus estimates.
Secondhand luxury marketplace The RealReal (NASDAQ: REAL) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 11.3% year on year to $160 million. The company expects next quarter’s revenue to be around $159 million, close to analysts’ estimates. Its non-GAAP loss of $0.08 per share was in line with analysts’ consensus estimates.
Refrigerant services company Hudson Technologies (NASDAQ:HDSN) announced better-than-expected revenue in Q1 CY2025, but sales fell by 15.2% year on year to $55.34 million. Its non-GAAP profit of $0.06 per share was significantly above analysts’ consensus estimates.
Personal care company The Honest Company (NASDAQ:HNST) reported Q1 CY2025 results exceeding the market’s revenue expectations, with sales up 12.8% year on year to $97.25 million. Its non-GAAP profit of $0.04 per share was $0.02 above analysts’ consensus estimates.
Semiconductor materials supplier Entegris (NASDAQ:ENTG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $773.2 million. On the other hand, the company expects next quarter’s revenue to be around $755 million, close to analysts’ estimates. Its non-GAAP profit of $0.67 per share was 2.4% below analysts’ consensus estimates.
Life sciences company Azenta (NASDAQ:AZTA) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.2% year on year to $143.4 million. Its non-GAAP profit of $0.05 per share was $0.03 below analysts’ consensus estimates.
Building systems company Limbach (NASDAQ:LMB) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 11.9% year on year to $133.1 million. The company’s full-year revenue guidance of $620 million at the midpoint came in 1.4% above analysts’ estimates. Its non-GAAP profit of $1.12 per share was significantly above analysts’ consensus estimates.
Radiopharmaceutical company Lantheus Holdings (NASDAQ:LNTH) missed Wall Street’s revenue expectations in Q1 CY2025, with sales flat year on year at $372.8 million. The company’s full-year revenue guidance of $1.57 billion at the midpoint came in 1.8% below analysts’ estimates. Its non-GAAP profit of $1.53 per share was 7.5% below analysts’ consensus estimates.
From a technical analysis perspective, today's price action further confirms what the charts have been telling us: the market is likely positioned for a meaningful decline regardless of news flow.
